Research shows SGLT2 inhibitors may reduce heart risks in diabetes patients.
― 6 min read
C. T. Chung
Research suggests SGLT2I may reduce prostate cancer risk in diabetic men.
― 6 min read
Study suggests SGLT2I may lower NPC risk in diabetes patients.
― 5 min read